Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

267.47

-15.68 (-5.54%)

At close: Jul 17, 2026, 4:00 PM EDT

267.47

0.00 (0.00%)

After-hours: Jul 17, 2026, 6:24 PM EDT

Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	577.22	313.75	-278.16	-440.24	-1,131	-852.82
Depreciation & Amortization	54.81	55.66	56.67	54.05	44.47	47.57
Stock-Based Compensation	361.68	348.24	272.08	221.68	230.65	165.72
Other Adjustments	186.94	251.22	155.18	211.4	307.15	160.67
Change in Receivables	-462.95	-359.96	-86.55	-87.94	-45.6	-101.8
Changes in Inventories	-1.07	8.47	13.59	18.37	-34.14	-26.42
Changes in Accounts Payable	56.77	75.07	91.09	80.84	191.77	88.24
Changes in Unearned Revenue	-24.95	-50.64	-235.45	55.02	-65.91	-50.4
Changes in Other Operating Activities	-91.28	-117.72	3.23	-9.03	-38.51	-72.45
Operating Cash Flow	714.9	524.08	-8.31	104.16	-541.27	-641.69
Capital Expenditures	-71.56	-58.7	-34.28	-62.21	-72.06	-76.37
Purchases of Investments	-1,180	-1,365	-1,712	-1,882	-2,075	-1,698
Proceeds from Sale of Investments	1,551	1,862	1,630	1,612	2,322	1,506
Other Investing Activities	-	-2.15	-0.12	-4.44	-4.69	-4.2
Investing Cash Flow	297.02	436.33	-116.84	-336.35	169.35	-273.3
Long-Term Debt Issued	-	645.69	-	-	1,016	500
Long-Term Debt Repaid	-	1,155	-	-	762.11	-
Net Long-Term Debt Issued (Repaid)	-	1,801	-	-	1,778	500
Issuance of Common Stock	213.82	250.03	302.95	147.46	259.36	246.27
Net Common Stock Issued (Repurchased)	213.82	250.03	302.95	147.46	259.36	246.27
Other Financing Activities	32.74	-46	-8.79	24.67	-87.61	500.85
Financing Cash Flow	-333.56	-305.19	294.16	172.13	425.75	1,247
Effect of Exchange Rate Changes on Cash and Cash Equivalents	13.81	34.94	-15.24	6.39	-7.43	-9.02
Net Cash Flow	690.17	690.16	153.77	-53.67	46.4	323.11
Free Cash Flow	643.34	465.38	-42.59	41.95	-613.33	-718.07
Free Cash Flow Growth	38.24%	-	-	-	-	-
FCF Margin	15.01%	12.53%	-1.89%	2.29%	-59.12%	-85.05%
Free Cash Flow Per Share	4.74	3.46	-0.33	0.34	-5.04	-6.06
Levered Free Cash Flow	499.94	2,026	-383.3	-303.2	672.69	-442.65
Unlevered Free Cash Flow	663.08	399.12	-235.52	-149.51	-762.35	-799.05

SEC Filings: 10-K · 10-Q